News Highlight

News Highlight RAG-17

Final results from an Investigator-Initiated Trial presented for the first time, demonstrating favorable safety, significant…

徐春杰April 9, 2025

Company News Homepage News News Highlight RAG-01

NANTONG, China, and MELBOURNE, Australia, March 24, 2025 – Ractigen Therapeutics, a clinical-stage biopharmaceutical company…

徐春杰March 24, 2025

Company News Homepage News News Highlight

NANTONG and SUZHOU, China, Dec. 30, 2024 — Ractigen Therapeutics proudly announces that its Founder…

Jiaqi HuangDecember 31, 2024

News Highlight

Jiangsu, China — Ractigen Therapeutics announced today that the U.S. Food and Drug Administration (FDA)…

ractigenMarch 3, 2023